Clinical Trial Update: WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial of WAL 801 CL Dry Syrup for paediatric atopic dermatitis has completed, according to the trial update from Boehringer Ingelheim.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• WAL 801 CL Dry Syrup

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Dermatitis, Atopic | Phase 3 | Status: COMPLETED